Reagents are the substance used in the chemical reaction for identifying the unknown substance. Reagents can be classified as primary and secondary standard reagents wherein primary are in pure form whereas secondary are obtained by mixing of primary and any solution. Biotechnology reagents are mainly used in basic research, therapeutics, biomedical, clinical trials and are primarily used by the food and beverage industry, pharmaceuticals and agro-biotech industry.

According to Zion Market Research, global demand for biotechnology reagents was valued at over USD 56.4 billion in 2015, is expected to reach above USD 94.6 billion in 2021 and is anticipated to grow at a CAGR of slightly above 9.0% between 2016 and 2021. Biotechnology reagents are utilized in various testing, clinical trials and even in diagnosis among others. This is expected to drive the market for biotechnology reagents in the near future. There has been tremendous growth in R&D expenditure by biotechnology and pharmaceutical firms which is likely to witness the foster growth of biotechnology reagent market. Conventional techniques such as combinatorial chemistry, DNA chips, high-throughput screening, and proteomics are anticipated to boost the demand for biotechnology reagent in the forecast period. However, huge research and development expenditure may impede the growth of biotechnology reagent market. Nevertheless, extensive use of biotechnology reagents in environment applications and untapped opportunities are likely to open new market avenues in the coming years.

Biotechnology regents consist of various technologies such as chromatography, electrophoresis, PCR, mass spectrometry, flow cytometry, expression, and transfection. Chromatography reagents and tissue culture reagents hold high potential for the growth of biotechnology reagents in the coming years. This is due to high use of tissue culture in agriculture whereas use of chromatography in the pharmaceutical sector. Some of the well-known applications of biotechnology reagents are DNA & RNA analysis, protein purification, drug testing, and gene expression. Protein purification followed by drug testing and gene expression accounted for the highest share in 2015 due to high demand from life science stream for innovating new products. End users for biotechnology reagents include biotech companies, pharmaceuticals, research institutes and diagnostic centers among others. Biotech companies are likely to exhibit high influence in the emerging economies such as Asia Pacific which is considered to positively impact on the growth of biotechnology reagents.

Browse the full report at

The biotechnology reagents market was dominated by North America in 2015. U.S held the largest market share in 2015 owing to the high use of biotechnology reagents in the molecular biology. Also, sophisticated healthcare sector in U.S is likely to boost the demand for biotechnology reagents in the near future. Europe was the second largest market in terms of consumption in 2015. This was mainly due to growing demand for biological regents in diagnosis. Asia Pacific is expected to spur the market growth in the forecast period owing to high accomplishment from the government for the development of biotechnology sector. Latin America, Middle East, and Africa are anticipated to experience moderate growth in the coming years.

Some of the key players for the biotechnology reagents market include Abbott, Beckman Coulter, Agilent Technologies Inc., Water Corporation, Bio-Rad, Roche, Sigma-Aldrich, Life Technologies, Becton Dickinson and Thermo Fisher Scientific among others.